Category Specific RSS

michael winlo

Testing methylone for PTSD treatment: Emyria’s Centre appointed site for clinical trial

Biotechnology company Emyria (ASX: EMD), which develops treatments for mental health and neurological conditions, has newly inaugurated its treatment facility…

1 year ago

TGA gives green light to Emyria’s psychiatrists for MDMA therapy for PTSD

Mental health treatment provider Emyria (ASX: EMD) has announced that its psychiatry specialist has been granted "Authorised Prescriber" status by…

2 years ago

Vape imports banned, Vitura introduces nicotine vaping products to tap new market

In a bid to crack down on excessive vaping among the Aussie youth, the Australian government decided to nip the…

2 years ago

Does IP ownership of MDMA compounds reduce its potential for healthcare benefits?

If you read my articles often, you would know that I can become quite laudatory when discussing small cap companies…

3 years ago

MDMA usage at University is through the roof as Emyria takes aim at mental health

Harbouring more MDMA than music festival goers, the University of Western Australia (UWA) is leading the way in research around…

4 years ago